Sources of European drug consumption data at a country level

Ferrer, Pili; Ballarín, Elena; Sabaté, Mònica; Laporte, Joan‐Ramon; Schoonen, Marieke; Rottenkolber, Marietta; Fortuny, Joan; Hasford, Joerg; Tatt, Iain; Ibáñez, Luisa

doi:10.1007/s00038-014-0564-8

Cited by 22 publications

(21 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From the inventory of nationwide administrative drug consumption databases included in the PROTECT project [3,4], 14 databases from 25 reviewed countries (Belgium, Bulgaria, Croatia, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Iceland, Ireland, Latvia, Lithuania, Norway, Poland, Portugal, Russia, Slovenia, Spain, Sweden, Switzerland, the Netherlands and the United Kingdom) offered available information of inhospital drug consumption.…”

Section: Resultsmentioning

confidence: 99%

“…In Italy, the information on medicines dispensed to patients while in the hospital is registered in regional databases, and that information is sent to the Italian Medicines Agency. Portugal collects information on medicines dispensed to patients while in the hospital, and this information includes the inpatient drug consumption definition and the medicines prescribed and supplied by the hospital to the outpatient [3,4]. Additionally, information on wholesalers' sales was available.…”

Section: Resultsmentioning

confidence: 99%

“…As part of the inventory on nationwide administrative drug consumption databases developed by the PROTECT Working Group on DU [3,4], information on drug consumption data in the inpatient sector was previously available for 14 countries.…”

Section: Methodsmentioning

confidence: 99%

“…In addition, we developed a questionnaire with the intention of collecting information on the items considered relevant when measuring drug exposure for the inpatient sector in the nationwide administrative drug consumption databases [3,4].…”

Section: Methodsmentioning

confidence: 99%

“…Very few countries have an organized system to collect inpatient DU at a national level [3,4] despite the fact that medicines prescribed in hospitals affect outpatient prescription and total pharmaceutical expenditure [5,6]. Inpatient medicine expenditure ranges from 8% of the total pharmaceutical expenditure in Germany to 35% in Denmark and Spain [7].…”

mentioning

confidence: 99%

See 4 more Smart Citations

Inpatient Drug Utilization in Europe: Nationwide Data Sources and a Review of Publications on a Selected Group of Medicines (PROTECT Project)

Sabaté¹,

Ferrer

Ballarín

et al. 2014

Basic Clin Pharma Tox

Self Cite

View full text Add to dashboard Cite

Drug utilization (DU) studies in inpatient settings at a national level are rarely conducted. The main objective of this study was to review the general information on hospital medicine management in Europe and to report on the availability and characteristics of nationwide administrative drug consumption databases. A secondary objective was to perform a review of published studies on hospital DU of a group of selected drugs, focusing on methodological characteristics (ATC/DDD). General information on hospital drug management was retrieved from several websites, nationwide administrative drug consumption databases and reports published by governmental organizations. A PubMed search was conducted using keywords related to the selected group of drugs AND 'hospital drug utilization'. The data sources for hospital DU information varied widely and included 14 databases from 25 reviewed countries. Bulgaria, Croatia, Denmark, Estonia, Finland, France, Hungary, Iceland, Latvia, Norway and Sweden obtain information on inpatient DU at a national level from wholesalers/manufacturers. In Belgium, Italy and Portugal, drugs dispensed to patients in hospitals are registered at a national level. Data are freely available online only for Denmark and Iceland. From the PubMed search, of a total of 868 retrieved studies, only 13 studies used the ATC/DDD methodology. Although the number of DDD/100 bed-days was used in four studies, other units of measure were also used. The type of information provided for the inpatient sector allowed primarily for conducting DU research at an aggregated data level. The existence of national administrative structures to monitor hospital DU would contribute to promoting the rational use of medicines and improving the safety and quality of prescribing.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations